[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
[ Thu, Oct 27th 2022 ]: WOPRAI
Tiago Fauth Maintained (BMRN) at Buy with Decreased Target to $110 on, Oct 27th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Tiago Fauth of Credit Suisse, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $111 to $110 on, Oct 27th, 2022.
Tiago has made no other calls on BMRN in the last 4 months.
There are 6 other peers that have a rating on BMRN. Out of the 6 peers that are also analyzing BMRN, 1 agrees with Tiago's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Luca Issi of "RBC Capital" Maintained at Hold with Increased Target to $95 on, Thursday, October 13th, 2022
These are the ratings of the 5 analyists that currently disagree with Tiago
- Jessica Fye of "JP Morgan" Maintained at Buy with Decreased Target to $112 on, Monday, October 24th, 2022
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $128 on, Tuesday, August 9th, 2022
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $125 on, Thursday, August 4th, 2022
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $122 on, Thursday, August 4th, 2022
- Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $110 on, Wednesday, July 13th, 2022